⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IBIO News
iBio, Inc. Common Stock
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans
globenewswire.com
IBO
IBIO
Lab-Grown Neurons Say "Hello, World!" and Perform Matrix Math on Automated Platform; Intactis Bio Corp Raises $250K from Nucleus Fund
prnewswire.com
IBIO
IntraBio Announces Submission of Supplemental New Drug Application for Levacetylleucine for Ataxia-Telangiectasia
businesswire.com
IBIO
Infinity Bio Appoints Brian McKelligon as Chief Executive Officer
businesswire.com
IBIO
iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
globenewswire.com
IBIO
Immorta Bio Demonstrates Dramatic Lifespan Extension in Aging Mouse Models; Research Accepted for Presentation at AAI's IMMUNOLOGY2026
prnewswire.com
IBIO
Form 8-K
sec.gov
IBIO
iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss
globenewswire.com
IBIO
Form 8-K
sec.gov
IBIO
SHINE Completes $240 Million in Recent Funding Led by Dr. Patrick Soon-Shiong, Founder of NantWorks, Who Joins Board of Directors
prnewswire.com
IBIO